BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17548534)

  • 1. Atorvastatin treatment and vaccination efficacy.
    Packard RR; Schlegel S; Senouf D; Burger F; Sigaud P; Perneger T; Siegrist CA; Mach F
    J Clin Pharmacol; 2007 Aug; 47(8):1022-7. PubMed ID: 17548534
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ezetimib plus statin combination. A strong duo].
    MMW Fortschr Med; 2002 Nov; 144(48):53. PubMed ID: 12532547
    [No Abstract]   [Full Text] [Related]  

  • 3. Atorvastatin: a new agent for hyperlipidemia.
    Kupecz D
    Nurse Pract; 1997 Nov; 22(11):87-8, 90, 93. PubMed ID: 9403876
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of increasing doses of atorvastatin on the atherogenic lipid subclasses commonly associated with hypertriglyceridemia.
    Karalis DG; Ishisaka DY; Luo D; Ntanios F; Wun CC
    Am J Cardiol; 2007 Aug; 100(3):445-9. PubMed ID: 17659926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sequelae of the CARDS Study. LDL of 110 mg/dl still too high?].
    Klose G
    MMW Fortschr Med; 2004 Jun; 146(26):14. PubMed ID: 15529683
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomised study to compare the efficacy and safety of isapgol plus atorvastatin versus atorvastatin alone in subjects with hypercholesterolaemia.
    Jayaram S; Prasad HB; Sovani VB; Langade DG; Mane PR
    J Indian Med Assoc; 2007 Mar; 105(3):142-5, 150. PubMed ID: 17824470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [High dosage stain protects heart and brain from recurrence].
    MMW Fortschr Med; 2008 Nov; 150(48):118-9. PubMed ID: 19125516
    [No Abstract]   [Full Text] [Related]  

  • 8. Rhabdomyolysis following co-prescription of fusidic acid and atorvastatin.
    Teckchandani S; Robertson S; Almond A; Donaldson K; Isles C
    J R Coll Physicians Edinb; 2010 Mar; 40(1):33-6. PubMed ID: 21125037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term atorvastatin treatment enhances specific antibody production following tetanus toxoid vaccination in healthy volunteers.
    Lee PY; Scumpia PO; Byars JA; Kelly KM; Zhuang H; Shuster JS; Theriaque DW; Segal MS; Reeves WH; Brantly ML
    Vaccine; 2006 May; 24(19):4035-40. PubMed ID: 16464519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First head-to-head study comparing rosuvastatin and atorvastatin effects on the treatment of atherosclerosis.
    Cardiovasc J Afr; 2008; 19(1):60. PubMed ID: 18320096
    [No Abstract]   [Full Text] [Related]  

  • 11. [High-dose statin in ischemic stroke reduces the risk of recurrent stroke].
    Crisby M; Olsson AG
    Lakartidningen; 2008 Nov 26-Dec 9; 105(48-49):3541-3. PubMed ID: 19133582
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of the efficacy of statin therapy in dyslipidemic diseases such as combined hypercholesterolemia IIA and hyperlipidemia].
    Liguori E; Sarcinella R
    Minerva Cardioangiol; 1998 Sep; 46(9):317-8. PubMed ID: 10021861
    [No Abstract]   [Full Text] [Related]  

  • 13. The influence of pravastatin and atorvastatin on markers of oxidative stress in hypercholesterolemic humans.
    Ky B; Burke A; Tsimikas S; Wolfe ML; Tadesse MG; Szapary PO; Witztum JL; FitzGerald GA; Rader DJ
    J Am Coll Cardiol; 2008 Apr; 51(17):1653-62. PubMed ID: 18436117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [How can lipid therapy be improved? Cardiologists insist on dual cholesterol inhibition].
    MMW Fortschr Med; 2005 Nov; 147(45):54. PubMed ID: 16320655
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety and efficacy of Atorvastatin-induced very low-density lipoprotein cholesterol levels in Patients with coronary heart disease (a post hoc analysis of the treating to new targets [TNT] study).
    LaRosa JC; Grundy SM; Kastelein JJ; Kostis JB; Greten H;
    Am J Cardiol; 2007 Sep; 100(5):747-52. PubMed ID: 17719314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of atorvastatin on hemorheological parameters in rabbits fed on a normal diet.
    Cefle K; Tamer S; Kaymaz AA; Balci M; Ahmetov S; Palanduz S; Ozturk S; Salmayenli N; Onar V
    Clin Hemorheol Microcirc; 2002; 26(4):265-71. PubMed ID: 12122232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein.
    Kappelle PJ; Zwang L; Huisman MV; Banga JD; Sluiter WJ; Dallinga-Thie GM; Dullaart RP
    Expert Opin Ther Targets; 2009 Jul; 13(7):743-51. PubMed ID: 19505224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atorvastatin and thrombogenicity of the carotid atherosclerotic plaque: the ATROCAP study.
    Cortellaro M; Cofrancesco E; Arbustini E; Rossi F; Negri A; Tremoli E; Gabrielli L; Camera M
    Thromb Haemost; 2002 Jul; 88(1):41-7. PubMed ID: 12152675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment with high-dose statin, but not low-dose statin, ezetimibe, or the combination of low-dose statin and ezetimibe, limits infarct size in the rat.
    Birnbaum Y; Lin Y; Ye Y; Merla R; Perez-Polo JR; Uretsky BF
    J Cardiovasc Pharmacol Ther; 2008 Mar; 13(1):72-9. PubMed ID: 18287593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of decreased plasma cholesterol by atorvastatin treatment on erythrocyte mechanical properties.
    Uyuklu M; Meiselman HJ; Baskurt OK
    Clin Hemorheol Microcirc; 2007; 36(1):25-33. PubMed ID: 17211059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.